Answers are grounded in this paper and cite their sources.
Supplementary Material 1. Fig. S1 NNK and arecoline induce EGFRvIII and splicing regulators in glioblastoma cells. S2 Schematic overview of canonical EGFRvIII, the PacBio Iso-Seq transcript PB.11430.142, and the lncRNA RP11-30P6.6. Fig. S3 RP11-30P6.6 promotes the proliferation, colony formation and migration of OSCC cells. Fig. S4 RP11-30P6.6 regulates EGFRvIII expression in DOK-AL and DOK-NNKL cells. Fig. S5 Identification of splicing factors regulating EGFRvIII exon skipping. Fig. S6 SRSF1 promotes malignant phenotypes in DOK-derived cells. Fig. S7 Schematic representation of putative miRNA-binding sites mapped within the EGFRvIII coding sequence. Fig.8 Co-transfection of RP11-30P6.6 partially attenuates candidate miRNA-mediated suppression of EGFRvIII expression. Fig.9 RP11-30P6.6 modulates the expression of candidate miRNAs associated with EGFRvIII regulation.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: